JS

Jagmohan Singh

Director Director DIN 03628356
DIN 03628356 First appointment Oct 2011 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Jagmohan Singh

Data last updated:

Jagmohan Singh was a Director at Cyclops Pharma Private Limited (2012–2015) and Director at Kashmir Buildtech & Constructions Private Limited (from 2011). The companies operate in Chemicals.

DIN 03628356
Primary Designation Director
Industry Chemicals
First Appointment 07 Oct 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cyclops Pharma Private Limited U24110JK2012PTC003762
Director28 Dec 20122012Strike Off
Director07 Oct 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kashmir Buildtech & Constructions Private Limited
Cyclops Pharma Private Limited
Premium access

Shareholding and investment profile for Jagmohan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagmohan Singh

Jagmohan Singh was first appointed on 07 Oct 2011 as Director at Kashmir Buildtech & Constructions Private Limited. The most recent appointment on record is 28 Dec 2012 at Cyclops Pharma Private Limited.

Jagmohan Singh held 2 earlier board appointments: Cyclops Pharma Private Limited (Director, 28 Dec 2012 to 20 Aug 2015); Kashmir Buildtech & Constructions Private Limited (Director, from 07 Oct 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available